First Visit FAQs

The first visit centres on the dermatology consultation: history-taking around the patient's presenting concern, examination of the relevant area or areas, photographic baseline establishment where the pathway warrants it, blood-work request where the picture suggests systemic context, and a calibrated written plan the patient leaves with. The framework treats the visit as a clinical conversation rather than as a sales appointment; the assessment determines the recommendation rather than the patient's arrival expectation.

A typical consultation runs around thirty to forty-five minutes, with longer windows for complex multi-concern cases. The framework calibrates the visit length to the case rather than to a fixed-package time slot. Patients should plan adequate time at the visit rather than scheduling immediately before another commitment.

Sometimes. For straightforward cases where the suitability assessment supports it, calibrated procedural work can begin at the first visit. For most cases the first visit ends with a written plan, and procedural work begins at a subsequent appointment after the patient has had time to consider the plan. The framework explicitly avoids "you must book your treatment today" sales pressure; decisions are made when the patient is ready rather than under time-limited offers.

The dermatologist consultation is priced at ₹1,999*; per-component pricing for any procedural pathway follows separately. The flat consultation fee covers the visit time, the clinical assessment, photographic baseline establishment where applicable, blood-work interpretation when applicable, and the written plan that the patient leaves with. Subsequent procedural sessions are priced separately per their respective pathways. The pricing structure is transparent at the time of booking, and the consultation itself does not commit the patient to any subsequent procedural pathway.

The consultation fee covers the consultation visit itself rather than committing the patient to subsequent treatment. The framework does not require treatment booking as a condition of the consultation. Patients who choose not to proceed with the recommended pathway have already received the calibrated assessment and written plan from the visit. Refund and rescheduling policy is detailed in the formal Refund, Cancellation and Rescheduling Policy in the policies section.

Useful items include any prior medical reports relevant to the presenting concern, the current list of medications and supplements (with doses where possible), photographs of any prior pattern relevant to trajectory tracking (selfies or older album images at known dates can help for hair-loss, pigmentation, and ageing pathways), prior treatment records if relevant, and the patient's questions written down so they are not forgotten in the visit. Patients without these items are not turned away; the consultation can begin without them and additional details follow at subsequent visits.

For pathways involving change over months or years — hair-loss patterns, ageing-related change, gradual pigmentation, evolving moles — historical photographs from the patient's own albums or social media at known dates can be informative for trajectory mapping. The clinic welcomes these where the patient has them. Patients without historical photographs are not at a disadvantage; the clinic-captured baseline at the visit is a sufficient starting point. The medical photography page covers the documentation framework.

Prior reports relevant to the presenting concern (blood-work, biopsy reports, prior dermatology assessments, prior procedural records) inform the consultation if available. The framework treats these as supportive inputs alongside the current examination; their absence does not prevent the consultation from proceeding. Patients can bring digital images on their phones rather than physical print-outs.

Disclose all current medications and supplements at the consultation, including over-the-counter products and herbal or traditional preparations. Selected medications affect dermatology pathway selection and calibration — photosensitising medications, isotretinoin within the previous several months, immunosuppression in some contexts, and selected hormonal medications all factor into the calibration. The framework treats full medication disclosure as part of the consultation.

Yes, particularly for younger patients accompanied by a parent or guardian, for patients who prefer support during the consultation, or where the visit covers significant decisions. The framework treats companion support as patient-supportive rather than as inconvenient. Companions are welcomed in the consultation room with the patient's consent.

Dress comfortably with the area of concern accessible for examination — for facial concerns, arrive without heavy makeup where possible. For body concerns, wear clothing that allows easy examination of the relevant zone. For hair-loss assessment, hair in everyday baseline state is appropriate (no extensive product or unusual styling on the day). Specific preparation for procedural visits — sun-avoidance windows, shaving for LHR, and similar — applies separately when procedural work is scheduled.

Where the pathway warrants a photographic baseline, the patient is informed before capture and consents at the time. Default use is clinical-record-only — supporting the patient's own care and the clinical conversation at follow-up — and any other use requires separate explicit consent. The framework treats photographs as patient health information rather than as marketing material. Patients who prefer not to be photographed are accommodated as far as is consistent with safe clinical practice. The formal Patient Consent and Photography Policy in the policies section carries the formal commitments.

For procedural pathways the appropriate informed-consent process precedes any procedural step. Consent covers the procedure, expected experience, residual risk, alternatives, and post-procedure expectations. The framework treats informed consent as substantive rather than as a paperwork hurdle; questions are welcomed at the consent stage and are answered before any procedure proceeds.

The dermatologist arrives at a calibrated recommendation through the consultation conversation. The patient receives the recommendation, the rationale, the alternatives that were considered, the realistic outcome range, and the residual risk profile. The patient leaves with the written plan and decides whether to proceed at a subsequent visit. The framework does not pressure same-day decisions; consideration time is part of how decisions are arrived at well rather than rushed.

Most patients leave the first visit with a written plan and time to consider it. The framework supports this rather than treating it as a sales-conversion problem. Patients can return to discuss specific elements, can defer the recommended pathway, or can choose not to proceed; the consultation has already produced calibrated value through the assessment regardless of subsequent booking.

Yes. The patient leaves the consultation with a written summary of the calibrated plan covering the recommendation, the rationale, the realistic outcome range, the maintenance pattern where applicable, and any blood-work or referral information. The framework treats the written plan as part of patient-facing transparency rather than as an optional handout. Patients can refer back to the plan when considering whether and when to proceed.

Follow-up cadence is calibrated to the pathway and the patient's observed response. For procedural pathways follow-up typically runs at three-to-six-month intervals during the active course with longer-interval review thereafter. For supportive-pathway patients (hair loss, pigmentation maintenance, anti-ageing trajectory), six-monthly to annual review is typical. The framework treats follow-up as ongoing rather than as the end of a project.

Patients can return for follow-up consultation, raise specific questions at scheduled visits, or contact the clinic between visits when relevant. The framework welcomes patient questions as part of the care continuum rather than as inconvenience. The complaints and grievance redressal policy in the policies section covers the formal channel for any concern that warrants formal handling.

Online or video-based consultation is appropriate in selected cases — initial orientation visits for patients who cannot easily reach the clinic, follow-up reviews where in-person examination is not necessary, and selected coordination visits. The framework recognises that some clinical decisions require in-person examination and routes those visits accordingly. The formal Teleconsultation Policy in the policies section covers the framework around online visits.